In a report released yesterday, Faisal Khurshid from Leerink Partners reiterated a Buy rating on Zura Bio. The company’s shares closed yesterday at $1.96. Elevate Your Investing ...

View the latest Spyre Therapeutics Inc. (SYRE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Explore the latest updates on Spyre Therapeutics Inc. (NASDAQ:SYRE) including share price, financial performance, dividend history, stock chart, and market insights. Stay informed with Kalkine Media.

IBM has introduced its latest Power11 enterprise servers in Germany, featuring the Spyre accelerator chip designed for AI inference. The chip is manufactured using Samsung Electronics' 5nm process ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic ...